Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit
Kura Oncology announced its participation in the TD Cowen 7th Annual Oncology Innovation Summit, scheduled for May 26, 2026. Company management will engage in a virtual fireside chat to discuss innovations related to oncology, highlighting Kura's progress with its pipeline and its approved drug KOMZIFTI™ for leukemia treatment.